Symrise
This article was originally published in The Rose Sheet
Executive Summary
Fragrance and flavors manufacturer will invest up to €46 mil. in German production sites over three years to "increase competitiveness," Symrise says. Initiative includes increasing employees' 37.5-hour workweek to 40 hours without wage increases and a two-year salary freeze. Firm also will receive government subsidies. Efforts will result in expanded production of fragrances and flavors at Symrise's Holzminden plant, consolidating natural flavor manufacturing at that site, but production also will continue at the Nordlingen facility...
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.